سعر برازوكوانتيل 1.8جم/15مل 15 شراب معلق 2022

Praziquantel oral suspension 1.8 g per 15 ml (15 ml bottle), T3A Pharma, for trematode and cestode infections.

• Schistosomiasis due to all Schistosoma speciesPopulation: Patients aged 1 year and olderDailyMed (US NLM)
• Clonorchiasis and opisthorchiasis (liver flukes)Population: Patients aged 1 year and olderDailyMed (US NLM)

• Hypersensitivity to praziquantel or excipients.General active-ingredient information · DailyMed (US NLM)
• Ocular cysticercosis (parasite destruction in the eye may cause irreversible lesions).General active-ingredient information · DailyMed (US NLM)
• Concomitant use of strong CYP3A inducers such as rifampin.General active-ingredient information · DailyMed (US NLM)

• Potentially life-threatening clinical deterioration when treated during the acute phase of schistosomiasis; possible lack of efficacy in acute schistosomiasis.General active-ingredient information · DailyMed (US NLM)
• May exacerbate CNS pathology (e.g. epilepsy, possible cysticercosis); cardiac arrhythmias have been reported; caution in hepatosplenic schistosomiasis with hepatic impairment.General active-ingredient information · DailyMed (US NLM)

• Strong CYP3A inducers (e.g. rifampin)Concomitant use is contraindicated because it may markedly reduce praziquantel exposure.DailyMed (US NLM)

• Published studies have not identified an association with use in pregnancy and major birth defects, miscarriage or adverse maternal/fetal outcomes; no adverse developmental outcomes in rat and rabbit studies.General active-ingredient information · DailyMed (US NLM)
• Praziquantel is present in human milk at low concentrations; no information on effects in the breastfed infant; weigh benefits of breastfeeding against maternal need.General active-ingredient information · DailyMed (US NLM)